UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 318

Sortiert nach

DMRcaller: a versatile R/Bioconductor package for detection and visualization of differentially methylated regions in CpG and non-CpG contexts

Nucleic acids research, 2018-11, Vol.46 (19), p.e114

2018

Volltextzugriff (PDF)

18F-Labeled brain-penetrant EGFR tyrosine kinase inhibitors for PET imaging of glioblastoma

Chemical science (Cambridge), 2023-12, Vol.14 (47), p.13825-13831

2023

Volltextzugriff (PDF)

18 F-Labeled brain-penetrant EGFR tyrosine kinase inhibitors for PET imaging of glioblastoma

Chemical science (Cambridge), 2023-12, Vol.14 (47), p.13825-13831

2023

Volltextzugriff (PDF)

F-Labeled brain-penetrant EGFR tyrosine kinase inhibitors for PET imaging of glioblastoma

Chemical science (Cambridge), 2023-12, Vol.14 (47), p.13825-13831

2023

Volltextzugriff (PDF)

The granular Blasius problem

Journal of fluid mechanics, 2019-08, Vol.872, p.784-817

2019

Volltextzugriff (PDF)

Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma

Nature medicine, 2017-11, Vol.23 (11), p.1342-1351

2017

Volltextzugriff (PDF)

Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis

Immunology, 2023-01, Vol.168 (1), p.152-169

2023

Volltextzugriff (PDF)

Picosecond-Resolved Fluorescence Studies of Substrate and Cofactor-Binding Domain Mutants in a Thermophilic Alcohol Dehydrogenase Uncover an Extended Network of Communication

Journal of the American Chemical Society, 2014-10, Vol.136 (42), p.14821-14833

2014

Volltextzugriff (PDF)

M2 isoform of pyruvate kinase rewires glucose metabolism during radiation therapy to promote an antioxidant response and glioblastoma radioresistance

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (11), p.1989-2000

2023

Volltextzugriff (PDF)

Development of a Potent Brain-Penetrant EGFR Tyrosine Kinase Inhibitor against Malignant Brain Tumors

ACS medicinal chemistry letters, 2020-10, Vol.11 (10), p.1799-1809

2020

Volltextzugriff (PDF)

Microstructural evaluation of the addition of Zr to create novel refractory high entropy alloys

Journal of materials science, 2023-12, Vol.58 (45), p.17405-17422

2023

Volltextzugriff (PDF)

CTNI-14. EVALUATING METABOLIC ALTERATIONS IN PATIENTS WITH EGFR ACTIVATED RECURRENT GLIOBLASTOMA (RGBM) BY INHIBITING EGFR WITH OSIMERTINIB

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Suppl 6), p.vi62-vi62

2021

Volltextzugriff (PDF)

Convolutional neural network based methodology for flexible phase prediction of high entropy alloys

Canadian metallurgical quarterly, 2024-06, p.1-13

2024

Volltextzugriff (PDF)

Interaction between the Blasius boundary layer and a free surface

Journal of fluid mechanics, 2018-03, Vol.839, Article R1

2018

Volltextzugriff (PDF)

Dopamine Receptor Antagonists, Radiation, and Cholesterol Biosynthesis in Mouse Models of Glioblastoma

JNCI : Journal of the National Cancer Institute, 2021-08, Vol.113 (8), p.1094-1104

2021

Volltextzugriff (PDF)

CTNI-14. EVALUATING METABOLIC ALTERATIONS IN PATIENTS WITH EGFR ACTIVATED RECURRENT GLIOBLASTOMA (RGBM) BY INHIBITING EGFR WITH OSIMERTINIB

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi62-vi62

2021

Volltextzugriff (PDF)

DDIS-08. DEVELOPMENT OF BRAIN-PENETRANT EGFR INHIBITORS FOR GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi70-vi70

2018

Volltextzugriff (PDF)

DDIS-17. DEVELOPMENT OF BRAIN-PENETRANT EGFR INHIBITORS FOR CNS MALIGNANCIES

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi66-vi66

2019

Volltextzugriff (PDF)

Surface Immobilization of Redox‐Labile Fluorescent Probes: Enabling Single‐Cell Co‐Profiling of Aerobic Glycolysis and Oncogenic Protein Signaling Activities

Angewandte Chemie International Edition, 2018-09, Vol.57 (36), p.11554-11558

International ed. in English, 2018

Volltextzugriff (PDF)

Axicabtagene Ciloleucel Manufacturing Experience from Launch to Present Day: A United States Perspective

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S203-S204

2024

Volltextzugriff (PDF)

EXTH-67. TG02, A BRAIN-PENETRANT MULTI-CDK INHIBITOR, POTENTLY SUPPRESSES MYC-DRIVEN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi87-vi88

2017

Volltextzugriff (PDF)

Surface Immobilization of Redox-Labile Fluorescent Probes Enables Single-Cell Co-Profiling of Aerobic Glycolysis and Oncogenic Protein Signaling Activities

Angewandte Chemie (International ed.), 2018-08, Vol.57 (36), p.11554-11558

2018

Volltextzugriff (PDF)

Identification, Development, and Evaluation of Brain-Penetrant Small-Molecule Inhibitors of Epidermal Growth Factor Receptor in Glioblastoma

Tsang, Jonathan Edward

2021

Volltextzugriff (PDF)

IMMU-50. SYSTEMIC ADOPTIVE TRANSFER IMMUNOTHERAPY WITH TCR-TRANSDUCED T-CELLS TARGETING NY-ESO-1 FOR MENINGIOMA

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi129-vi130

2019

Volltextzugriff (PDF)

Risk Management in Biologics Technology Transfer

PDA journal of pharmaceutical science and technology, 2016-11, Vol.70 (6), p.596

2016

Volltextzugriff (PDF)

1 – 25 von 318

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(267)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

DMRcaller: a versatile R/Bioconductor package for detection and visualization of differentially methylated regions in CpG and non-CpG contexts

18F-Labeled brain-penetrant EGFR tyrosine kinase inhibitors for PET imaging of glioblastoma

18 F-Labeled brain-penetrant EGFR tyrosine kinase inhibitors for PET imaging of glioblastoma

F-Labeled brain-penetrant EGFR tyrosine kinase inhibitors for PET imaging of glioblastoma

The granular Blasius problem

Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma

Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis

Picosecond-Resolved Fluorescence Studies of Substrate and Cofactor-Binding Domain Mutants in a Thermophilic Alcohol Dehydrogenase Uncover an Extended Network of Communication

M2 isoform of pyruvate kinase rewires glucose metabolism during radiation therapy to promote an antioxidant response and glioblastoma radioresistance

Development of a Potent Brain-Penetrant EGFR Tyrosine Kinase Inhibitor against Malignant Brain Tumors

Microstructural evaluation of the addition of Zr to create novel refractory high entropy alloys

CTNI-14. EVALUATING METABOLIC ALTERATIONS IN PATIENTS WITH EGFR ACTIVATED RECURRENT GLIOBLASTOMA (RGBM) BY INHIBITING EGFR WITH OSIMERTINIB

Convolutional neural network based methodology for flexible phase prediction of high entropy alloys

Interaction between the Blasius boundary layer and a free surface

Dopamine Receptor Antagonists, Radiation, and Cholesterol Biosynthesis in Mouse Models of Glioblastoma

CTNI-14. EVALUATING METABOLIC ALTERATIONS IN PATIENTS WITH EGFR ACTIVATED RECURRENT GLIOBLASTOMA (RGBM) BY INHIBITING EGFR WITH OSIMERTINIB

DDIS-08. DEVELOPMENT OF BRAIN-PENETRANT EGFR INHIBITORS FOR GLIOBLASTOMA

DDIS-17. DEVELOPMENT OF BRAIN-PENETRANT EGFR INHIBITORS FOR CNS MALIGNANCIES

Surface Immobilization of Redox‐Labile Fluorescent Probes: Enabling Single‐Cell Co‐Profiling of Aerobic Glycolysis and Oncogenic Protein Signaling Activities

Axicabtagene Ciloleucel Manufacturing Experience from Launch to Present Day: A United States Perspective

EXTH-67. TG02, A BRAIN-PENETRANT MULTI-CDK INHIBITOR, POTENTLY SUPPRESSES MYC-DRIVEN GLIOBLASTOMA

Surface Immobilization of Redox-Labile Fluorescent Probes Enables Single-Cell Co-Profiling of Aerobic Glycolysis and Oncogenic Protein Signaling Activities

Identification, Development, and Evaluation of Brain-Penetrant Small-Molecule Inhibitors of Epidermal Growth Factor Receptor in Glioblastoma

IMMU-50. SYSTEMIC ADOPTIVE TRANSFER IMMUNOTHERAPY WITH TCR-TRANSDUCED T-CELLS TARGETING NY-ESO-1 FOR MENINGIOMA

Risk Management in Biologics Technology Transfer

Suchergebnisse filtern